is Going Hybrid!
Bringing together leading genomic researchers, healthcare professionals, and healthcare industry stakeholders to usher in a new era of precision medicine.
Join in person or virtually for an outstanding 2.5 days of cutting-edge science, provocative discoveries and major initiatives in genomic medicine.
March 3, 2022
This is the preeminent genome science and technology conference for top global researchers, leaders and innovators.
This is a new scientific conference focusing on the global impact of breakthrough innovations made possible through agricultural genomics.
AGBT is the world-renowned not-for-profit provider of three prestigious conference and networking events for the leading luminaries and change-makers of the life sciences and global biotech community.
AGBT delivers a trifecta of preeminent conferences and networking events for the world’s top genome science and technology researchers, leaders, and innovators to share the latest advances, discoveries, and breakthroughs with influential peers and key decision-makers.
By providing opportunities for the global scientific community and technology industry to gather and collaborate in casual, intimate settings, AGBT functions as a key player in advancing DNA sequencing technologies, driving novel applications, and furthering experimental and analytical approaches for genomic studies in the public and private sectors.
Among our attendees are heads of internationally regarded labs and institutions, C-suite executives of life science companies, Wall Street analysts, and media representatives.
Regardless of their role, AGBT brings together those with a shared commitment to pioneering the frontiers of genome science and technologyfor forging a new future and better world.
AGBT Precision Health 2021 Speakers
The Genome Partnership
The Genome Partnership has been proudly organizing The Advances in Genome Biology and Technology (AGBT) meetings since 1999. The Genome Partnership is a not-for-profit organization and its mission is to advance research, promote education, and expand commerce in genome science and technology.